Document 6577112

Comments

Transcription

Document 6577112
ISR AUTUMN 2014 MEETING held on Thursday 11th & Friday 12th September (Fitzpatrick Castle Hotel, Killiney - Co.Dublin)
AWARD
PRESENTED TO
Dr Lorna Gallagher:
Young
Adelaide & Meath
Investigator Hospital, Tallaght
ABSTRACT TITLE
ABSTRACT NO./REF
14A160
Pseudostarvation by AMPK activator therapy is associated with reduced disease activity and downregulation of pro-inflammatory
responses in Rheumatoid Arthritis (RA)
Abstract 4 (14A156)
MTX inhibits maigrational and invasive mechanisms in Rheumatoid Arthritis
Ist Oral
Sian Cregan: School of
Medicine & Medical
Science, UCD
2nd Oral
Dr S A Ramakrishnan:
Our Lady's Hospital,
Navan
Abstract 7 (14A111)
Outcome of Treat of Target (T2T) in newly diagnosed Rheumatoid Arthritis (RA) at Rheumatology Department, Our Lady's Hospital,
Navan
1st Poster
Bernie McGowan:
Our Lady's Hospital,
Manorhamilton
Abstract 14 (14A103)
Adherence and persistence to urate-lowering therapies in the Irish setting
2nd Poster
Dr Lorraine O'Neill:
Dublin Academic Medical
Centre, SVUH
Abstract 63 (14A183)
Altered miRNA expression in Giant Cell Arteritis
Case Oral
Dr F A Ashraf: University
Hospital Limerick
14A177
Budd-Chiari syndrome in a patient with intestinal Behcet’s disease: Two recognized complications with serious and devastating
outcome that should not be missed

Similar documents

Global Rheumatoid Arthritis Diagnosis Test market is expected to be valued at US$ 738.7 Mn by the end of 2022

Global Rheumatoid Arthritis Diagnosis Test market is expected to be valued at US$ 738.7 Mn by the end of 2022 Global rheumatoid arthritis diagnosis tests market has been estimated to be valued at US$ 485.5 Mn in 2015, and is anticipated to increase to US$ 738.7 Mn by 2022, registering a CAGR of 6.2% during the forecast period. Incidence of RA are increasing among children in Europe and North America. This increased incidence rate calls for adoption of minimally-invasive test methods to diagnose rheumatoid arthritis. Hence, there is high demand for RA test kits with minimally-invasive testing method in Europe and North America.

More information